Next Article in Journal
A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [177Lu]Ludotadipep for Patients with Metastatic Castration-Resistant Prostate Cancer: Phase I Clinical Trial
Next Article in Special Issue
Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer
Previous Article in Journal
Natural Compounds in Liposomal Nanoformulations of Potential Clinical Application in Glioblastoma
Previous Article in Special Issue
Risk Factors for Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-Analysis
 
 
Article

Article Versions Notes

Cancers 2022, 14(24), 6224; https://doi.org/10.3390/cancers14246224
Action Date Notes Link
article pdf uploaded. 16 December 2022 16:29 CET Version of Record https://www.mdpi.com/2072-6694/14/24/6224/pdf-vor
article xml file uploaded 21 December 2022 06:17 CET Original file -
article xml uploaded. 21 December 2022 06:17 CET Update https://www.mdpi.com/2072-6694/14/24/6224/xml
article pdf uploaded. 21 December 2022 06:17 CET Updated version of record https://www.mdpi.com/2072-6694/14/24/6224/pdf
article html file updated 21 December 2022 06:18 CET Original file -
article html file updated 1 March 2023 04:42 CET Update -
article html file updated 4 March 2023 22:24 CET Update https://www.mdpi.com/2072-6694/14/24/6224/html
Back to TopTop